Evidence map›Paper›PMID 9166426›Full record

ArticleThe Journal of experimental medicine1997

T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis.

R Sciammas, P Kodukula, Q Tang, R L Hendricks, J A Bluestone

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 173 citations in OpenAlex.

  1. Trial
  2. Review
  3. Impact ofTropical medicine and infectious disease · 2025
    Article
  4. Article
  5. Expansion of effector memory Vδ2Frontiers in immunology · 2024
    Article
  6. Article
  7. Review
  8. Pathobiology and treatment of viral keratitis.Experimental eye research · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. The Role of γδ T Cells in Systemic Lupus Erythematosus.Journal of immunology research · 2016
    Review
  17. Article
  18. Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.Annals of clinical and translational neurology · 2015
    Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R SciammasBen May Institute for Cancer Research, Department of Pathology and Committee on Immunology, University of Chicago, Chicago, Illinois 60637, USA.
P Kodukula
Q Tang
R L Hendricks
J A Bluestone
May Institute · USUniversity of Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YAO, XINCHENG · 1985 to 2025
$14.8M
ROLE OF CYTOTOXIC LYMPHOCYTES IN HSV-1 CORNEAL LESIONSR01EY005945 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HENDRICKS, ROBERT L · 1986 to 2017
$8.3M
CYTOKINES AND ADHESION MOLECULES IN HSV KERATITISR01EY010359 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HENDRICKS, ROBERT L · 1994 to 2011
$4.9M
IMMUNOBIOLOGY OF TCR GAMMA/DELTA T-CELLSR01AI026847 · NIAID · UNIVERSITY OF CHICAGO · PI BLUESTONE, JEFFREY A · 1988 to 1997
–
NEI NIH HHS EY10359NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY005945NEI NIH HHS R01 EY010359NIAID NIH HHS R01 AI26847
6 · The paper itself

Abstract

Increased numbers of T cell receptor (TCR)-gamma/delta cells have been observed in animal models of influenza and sendai virus infections, as well as in patients infected with human immunodeficiency virus and herpes simplex virus type 1 (HSV-1). However, a direct role for TCR-gamma/delta cells in protective immunity for pathogenic viral infection has not been demonstrated. To define the role of TCR-gamma/delta cells in anti-HSV-1 immunity, TCR-alpha-/- mice treated with anti- TCR-gamma/delta monoclonal antibodies or TCR-gamma/delta x TCR-alpha/beta double-deficient mice were infected with HSV-1 by footpad or ocular routes of infection. In both models of HSV-1 infection, TCR-gamma/delta cells limited severe HSV-1-induced epithelial lesions and greatly reduced mortality by preventing the development of lethal viral encephalitis. The observed protection resulted from TCR-gamma/delta cell-mediated arrest of both viral replication and neurovirulence. The demonstration that TCR-gamma/delta cells play an important protective role in murine HSV-1 infections supports their potential contribution to the immune responses in human HSV-1 infection. Thus, this study demonstrates that TCR-gamma/delta cells may play an important regulatory role in human HSV-1 infections.

Indexed as

AnimalsEncephalitis, ViralHerpes SimplexImmunohistochemistryInterferon-gammaKeratitis, HerpeticMiceMice, Inbred BALB CMice, Inbred C57BLReceptors, Antigen, T-Cell, gamma-deltaSimplexvirusT-LymphocytesTrigeminal GanglionVirus ReplicationInterferon-gammaReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID9166426
PMCPMC2196341
OpenAlexW2120042716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.